|

Ayla Annac, Invivosciences
Jovan Antunovic, Abbott
Jay Berfas, Pharmaceutical Executive and Pharmaceutical Representative
Steve Bliss, Innovex
Joanna Breitstein, Pharmaceutical Executive
Mike Capaldi, Sanofi-Aventis
Lorrie Carr, Schering-Plough
Patrick Clinton (Conference Chair), Pharmaceutical Executive
Trevor Deal, Formulary and Managed Healthcare Executive
David Duve, King Pharmaceuticals
Barri Falk, Serono
Scott W. Fedak, Wyeth
Sander Flaum, Flaum Partners
James Forte, Campbell Alliance
Blair Gibson, Merck
Scott Hull, Abbott
Harris Kaplan, Healogix
Ayse Kocak, Pfizer
John Kuchna, Strategic Outcomes
Jorge Lorenzo, Noven Pharmaceuticals
Michael Luby, Target Rx
William McLean, Daiichi Sankyo
Julie Miller, Managed Healthcare Executive
Min Park, PDI
Andrea Paskman, AstraZeneca
Peter H. Rheinstein, JD, MD, MS, Severn Health Solutions
Kent Rogers, Schering-Plough
Jennifer Stahl, Bayer
Stan Striker, Maritz Incentives
Terese Waldron, Saint Joseph’s University, Erivan K. Haub School of Business
Tara Stultz, Advanstar Communications Sr. Content Producer/Program Director
|
  
|